Table 2.
Nanosystem | Size | Advantage | Limitations | References |
---|---|---|---|---|
Solid lipid nanoparticles (SLN) | 50–1000 nm | Biocompatible; Biodegradable; High drug loading; Good stability; Enhanced bioavailability; Excellent nanocarriers for controlled release and for targeted drug delivery to the reticuloendothelial system. |
Costly and complex methods of preparation; Expulsion of the drug from the SLNs over time; Only suitable for loading hydrophobic drugs. |
[16,30,36,37,38] |
Liposomes | 25–2500 nm | Loading simultaneously with two drugs (hydrophobic and hydrophilic); Easy functionalization of the surface; Biocompatible; Low toxicity; Biodegradable. |
Costly and complex methods of preparation. | |
Nanoemulsions | <100 nm | Loading simultaneously with two drugs (hydrophobic and hydrophilic); Facilitate the bioenhancement of hydrophobic drugs; |
Not form spontaneously; Considerable energy is required to generate nanoemulsions; Limited stability; Lack of controlled release functions; Tendency to flocculate and coalescent. |
|
Micelles | 5–100 nm | Easy loading of hydrophobic drug; Enhanced permeability; Low toxicity; Extended blood half-life |
Low loading efficacy; Instability. |
|
Polymeric nanoparticles | <1000 nm | High drug loading capacity; Drug release regulated by selecting; Appropriate preparation methods; High stability; High membrane permeability; Biodegradable; Easy functionalization of the surface. |
Costly and complex methods of preparation; Prone to aggregation and opsonization in the bloodstream; Need of functionalization. |
|
Polymeric micelles | 10–100 nm | Easy and high loading hydrophobic drug; Drug release regulated by polymers structure; Small size; Prevention of rapid clearance by reticuloendothelial system; Low CMC Easy and cheap preparation; Biocompatible; Extended circulation time; Lower toxicity of a drug; High stability in vitro and in vivo |
Complex characterization; Lack of stability in blood; Limited number of polymers for use; Lack of suitable methods for scale-up; Dependency of critical micelle concentration. |
|
Dendrimers | 1–10 nm | High drug loading capacity; Small size; Versatility of surface functionalization. |
High cytotoxicity; Haemolytic properties; Non-biodegradable; Not a good candidate carrier for hydrophilic drugs; Elimination and metabolism depending on the generation and materials; High cost for their synthesis. |
|
Inorganic Nanoparticle | 1–100 nm | Stimuli-responsive behavior; Good microbial resistance and good storage properties; Versatility of surface functionalization. |
Poor data regarding long-term exposure; Toxicity and instability. |
|
Nanocrystal | <500 nm | Well-understood and established manufacturing techniques; Excellent reproducibility; Applicable to drugs with different solubility profiles; Suitable for oral administration; |
Requires high energy input that drives up costs; Needs further modification to ensure stability; Lack of controlled release functions. |
[39] |